Clinical Practice of AECOPD Management in China

NCT02051166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5095

Last updated 2016-06-15

No results posted yet for this study

Summary

The purpose of this study is observe clinical practice including glucocorticoids treatment in AECOPD in China.

Conditions

  • Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Sponsors & Collaborators

Principal Investigators

  • Wanzhen Yao, Ph.D · Peking University Third Hospital

Eligibility

Min Age
40 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02051166 on ClinicalTrials.gov